Cargando…
Colorectal cancer and NF-κB signaling pathway
Colorectal cancer (CRC) is the second leading cause of cancer death. Progress has been made in the development of chemotherapy for advanced CRC. Targeted therapies against VEGF or EGFR are now commonly used. However, many cases show that tolerance develops to such treatments; therefore, new strategi...
Autor principal: | Hassanzadeh, Parichehr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Institute for Gastroenterology and Liver Diseases
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017424/ https://www.ncbi.nlm.nih.gov/pubmed/24834170 |
Ejemplares similares
-
Molecular profile of the NF‐κB signalling pathway in human colorectal cancer
por: Dobre, Maria, et al.
Publicado: (2022) -
Asiaticoside suppresses cell proliferation by inhibiting the NF-κB signaling pathway in colorectal cancer
por: Zhou, Xin, et al.
Publicado: (2020) -
Role of the NFκB-signaling pathway in cancer
por: Xia, Longzheng, et al.
Publicado: (2018) -
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway
por: Liu, Bin, et al.
Publicado: (2023) -
ICAT promotes colorectal cancer metastasis via binding to JUP and activating the NF‐κB signaling pathway
por: Wang, Zihan, et al.
Publicado: (2022)